Regression outputs (p-values) relating pharmacokinetic properties to patients’ characteristics.

Inferred parameters from the fitted pharmacokinetic model, specifically the median values of albendazole sulfoxide (AlbSO) systemic availability, albendazole sulfoxide clearance rate, albendazole sulfoxide AUC400 and CMax400 were regressed onto various patient group demographic and treatment metadata.

对拟合药代动力学模型（pharmacokinetic model）所得的推断参数，具体为阿苯达唑亚砜（albendazole sulfoxide，AlbSO）的系统生物利用度、清除率、AUC400与CMax400的中位数，以各类患者人群的人口统计学特征及治疗相关元数据为自变量开展回归分析。